| Melissa M Olson, PHARMD | |
|
2323 E Colorado Blvd, Spearfish, SD 57783-3203 | |
| (605) 642-8749 | |
| Not Available |
| Full Name | Melissa M Olson |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2323 E Colorado Blvd, Spearfish, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558797191 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 5953 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Melissa M Olson, PHARMD 1105 Deadwood St, Sturgis, SD 57785-2309 Ph: () - | Melissa M Olson, PHARMD 2323 E Colorado Blvd, Spearfish, SD 57783-3203 Ph: (605) 642-8749 |
News Archive
Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, today announced the eagerly awaited global launch of the Syro Wave™; their new microwave and parallel peptide synthesizer. The Syro Wave™ is a result of the joint development project announced last year between Biotage and MultiSynTech. It combines the proven performance of the established MultiSynTech robotic synthesizer with Biotage microwave technology.
Envoy Therapeutics, Inc., a newly formed drug discovery company, today announced that it has secured a loan from Takeda Research Investment (TRI) which Envoy may elect to convert to Envoy preferred stock should the company complete a second private equity financing. TRI will receive certain rights from Envoy related to a specific therapeutic field while scientists at the two companies craft a broad scientific research alliance.
Critical Biologics Corporation (CBC) and Scarab Genomics announced today a strategic agreement to substantially increase the manufacturing yield of CBC's lead therapeutic protein candidate, Solinex™, an intravenous formulation of recombinant human plasma gelsolin (rhu-pGSN).
An international team of researchers has found that the use of bisphosphonates - drugs already taken by millions of healthy women to prevent bone-loss - for more than one year was associated with a 50 percent reduction in the risk of postmenopausal colorectal cancer. The results were published this week in the Journal of Clinical Oncology.
Loyola University Health System was excited to be a part of the first annual Turn Up Your Health Youth Wellness Challenge, which encouraged young people in the Maywood community to make healthy lifestyle choices.
› Verified 7 days ago
Mary Ables, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2825 1st Ave, Spearfish, SD 57783 Phone: 605-642-3025 | |
Krista Stevens, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1430 North Ave, Spearfish, SD 57783 Phone: 605-642-0650 | |
April Leanna Owen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1606 North Ave, Suite #2, Spearfish, SD 57783 Phone: 605-642-3039 Fax: 605-644-0744 | |
Chelsea Rendleman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1606 North Ave, Spearfish, SD 57783 Phone: 605-642-3039 Fax: 605-644-0744 | |
Mr. Don G Abrahamson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1606 North Ave, Suite #2, Spearfish, SD 57783 Phone: 605-642-4747 | |
Austin James Kott, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2825 1st Ave, Spearfish, SD 57783 Phone: 605-642-3025 Fax: 605-642-1832 | |
Mr. Kent Stephen Kennon, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1606 North Ave, Safeway Pharmacy, Spearfish, SD 57783 Phone: 605-342-3909 |